Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eRapa in Familial Adenomatous Polyposis
NCT04230499Phase 2Completed
- Sponsor
- Emtora Biosciences
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in familial adenomatous polyposis (FAP), sponsored by Emtora Biosciences. Started Jan 2021; status: completed.
02
Drugs
sirolimus
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT04230499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04230499.